Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-16

Clinical Trial Update: Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating suvorexant for improving daytime sleep in shift workers has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Suvorexant (suvorexant)

Snippet

Sponsor: VA Palo Alto Health Care System | Conditions: Sleep Disorder, Shift-Work | Phase 4 | Status: COMPLETED | Results posted: 2020-06-16